Cytovance recently appeared on the Outsourced Pharma Large Molecule Capacity Update to share how our available capacity,  current microbial and mammalian capabilities, US-based manufacturing, and high scale-up success rate are helping industry customers meet product milestones.

View the video below to hear from Thomas O. Kohl, PhD, our Senior Director of Business Development, on the agility and experience that make Team Cytovance the ideal CDMO partner for your clinical and commercial programs.